| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.003 |